Tyrosine kinase inhibitor–induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling

C Riether, CM Schürch, C Flury… - Science translational …, 2015 - science.org
In chronic myelogenous leukemia (CML), oncogenic BCR-ABL1 activates the Wnt pathway,
which is fundamental for leukemia stem cell (LSC) maintenance. Tyrosine kinase inhibitor …
被引用次数：93 相关文章

Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling.

C Riether, CM Schürch, C Flury… - Science translational …, 2015 - sonar.ch
English In chronic myelogenous leukemia (CML), oncogenic BCR-ABL1 activates the Wnt
pathway, which is fundamental for leukemia stem cell (LSC) maintenance. Tyrosine kinase …

Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling

C Riether, CM Schürch, C Flury… - Science …, 2015 - pubmed.ncbi.nlm.nih.gov
In chronic myelogenous leukemia (CML), oncogenic BCR-ABL1 activates the Wnt pathway,
which is fundamental for leukemia stem cell (LSC) maintenance. Tyrosine kinase inhibitor …

Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling.

C Riether, CM Schürch, C Flury… - Science Translational …, 2015 - europepmc.org
In chronic myelogenous leukemia (CML), oncogenic BCR-ABL1 activates the Wnt pathway,
which is fundamental for leukemia stem cell (LSC) maintenance. Tyrosine kinase inhibitor …

[引用][C] Tyrosine kinase inhibitor–induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling

C Riether, CM Schürch, C Flury… - Science Translational …, 2015 - cir.nii.ac.jp
Tyrosine kinase inhibitor–induced CD70 expression mediates drug resistance in leukemia stem
cells by activating Wnt signaling | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

Tyrosine kinase inhibitor–induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling.

C Riether, CM Schürch, C Flury… - Science …, 2015 - search.ebscohost.com
The article looks at a study regarding Tyrosine kinase inhibitor–induced CD70 expression
mediates drug resistance in leukemia stem cells by activating Wnt signaling. It mentions TKIs …
[PDF] researchgate.net

[PDF][PDF] Tyrosine kinase inhibitor–induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling

C Riether, CM Schürch, C Flury, M Hinterbrandner… - researchgate.net
In chronic myelogenous leukemia (CML), oncogenic BCR-ABL1 activates the Wnt pathway,
which is fundamental for leukemia stem cell (LSC) maintenance. Tyrosine kinase inhibitor …

Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling.

C Riether, CM Schürch, C Flury… - Science translational …, 2015 - folia.unifr.ch
English In chronic myelogenous leukemia (CML), oncogenic BCR-ABL1 activates the Wnt
pathway, which is fundamental for leukemia stem cell (LSC) maintenance. Tyrosine kinase …
[PDF] archive.org

[PDF][PDF] Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt-signaling

C Riether, CM Schürch, C Flury, M Hinterbrandner… - scholar.archive.org
In chronic myelogenous leukemia (CML), oncogenic BCR-ABL1 activates the Wnt pathway,
which is fundamental for leukemia stem cell (LSC) maintenance. Tyrosine kinase inhibitor …

Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling.

C Riether, C Schürch, C Flury… - Science translational …, 2015 - boris.unibe.ch
In chronic myelogenous leukemia (CML), oncogenic BCR-ABL1 activates the Wnt pathway,
which is fundamental for leukemia stem cell (LSC) maintenance. Tyrosine kinase inhibitor …